UP!

RBCN $1.3

RBCN target price
1.30
0
0
Rubicon Technology Inc.
Type
Public
Traded as NASDAQ: RBCN
Industry Material, sapphire substrates
Founded 2001
Website rubicontechnology.com

Rubicon Technology, Inc. is an American company specializing in sapphire crystal growth technology and large-diameter sapphire based on improved Kyropoulos technology called ES2. Improvements to the Kyropoulos technology were developed in its Illinois-based crystal growth facilities. The company has been producing the industry's first 12-inch sapphire wafer since 2010, and has shipped millions of wafers and core products in sizes from 2" to 12" since 2001. The company's markets have been focused on the LED industry and the production of silicon on sapphire (SOS) wafers for integrated circuits (RFICs), as well as on high quality optical and industrial applications for high performance sapphire. The company's current market capitalization is down from around US$ 200 million to $13 million, with an enterprise value (November 2013 to December 2016) from around US$ 160 million to less than zero.

In 2000, Rubicon Technology began its commercial production and was incorporated in 2001. It had successful growth of 30 kg sapphire boule in 2002. In 2003, its polishing capacity was added and it received ISO9001 certification in the following year. In 2013, Rubicon launched 4" and 6" Patterned Sapphire Substrates (PSS), extending vertical integration "from powder to pattern".

Rubicon Technology is engaged in developing, manufacturing and selling monocrystalline sapphire and other crystalline products for light-emitting diodes (LEDs), radio-frequency integrated circuits (RFICs), optoelectronics, and other optical applications.

Rubicon Technology produces Patterned Sapphire Substrates (PSS) in 4" through 8" diameters. The company also produces sapphire ingots, which are used as raw material for further fabrication. Additionally, Rubicon produces optical windows, with applications ranging from defense/aerospace and instrumentation to medical devices, and polished epi-ready substrates.

Q reports

Period Date Adjusted Actuals EPS GAAP EPS

Ratings

2016-05-11 Reiterated Rating Canaccord Genuity Hold $0.75
2016-02-25 Reiterated Rating Canaccord Genuity Hold $1.05 to $0.90
2015-11-10 Reiterated Rating Oppenheimer Hold
2015-11-10 Reiterated Rating Canaccord Genuity Hold $1.65 to $1.05
2015-11-10 Reiterated Rating Oppenheimer Holdings Inc. Hold
2015-10-15 Reiterated Rating Northland Securities Market Perform
2015-08-07 Reiterated Rating Canaccord Genuity Hold $3.50 to $1.65
2015-08-07 Reiterated Rating Oppenheimer Market Perform
2015-05-08 Reiterated Rating Canaccord Genuity Hold $3.50
2015-02-25 Reiterated Rating Needham & Company LLC Buy
2015-02-13 Reiterated Rating Canaccord Genuity Hold $5.00
2014-11-07 Reiterated Rating Canaccord Genuity Hold $8.00 to $5.00
2014-11-07 Downgrade Dougherty & Co Buy to Neutral
2014-10-13 Reiterated Rating Dougherty & Co Positive
2014-08-08 Downgrade JPMorgan Chase & Co. Overweight to Neutral $13.00 to $8.00
2014-08-08 Downgrade Canaccord Genuity Buy to Hold $10.00 to $8.00
2014-07-23 Initiated Coverage Goldman Sachs Sell $6.00
2014-07-23 Initiated Coverage Goldman Sachs Group Inc. Sell $6.00
2014-06-06 Reiterated Rating Canaccord Genuity Buy $14.00 to $10.00
2014-05-23 Upgrade Oppenheimer Underperform to Market Perform $7.50
2014-05-13 Initiated Dougherty & Company Buy $11
2014-05-13 Initiated Coverage Dougherty & Co Buy $11.00
2014-05-02 Lower Price Target Canaccord Genuity $15.00 to $14.00
2014-04-01 Upgrade JPMorgan Chase & Co. Neutral to Overweight $12.00 to $14.00
2014-03-28 Reiterated UBS Neutral $9.50 to $12
2014-03-26 Reiterated Rating Canaccord Genuity Buy $15.00
2014-03-18 Boost Price Target DA Davidson $13.00 to $17.00
2014-03-17 Boost Price Target DA Davidson $13.00 to $17.00
2014-03-06 Downgrade Summit Research Hold to Sell $9.50
2014-02-20 Boost Price Target JPMorgan Chase & Co. $7.50 to $12.00
2014-02-20 Boost Price Target Canaccord Genuity $12.00 to $15.00
2013-10-30 Lower Price Target Sterne Agee CRT Buy $18.00 to $17.00
2013-10-30 Boost Price Target Piper Jaffray Underweight $3.00 to $5.00
2013-10-30 Lower Price Target Oppenheimer Underperform $9.00 to $7.50
2013-10-30 Lower Price Target Lazard Capital Markets Buy $14.00 to $12.00
2013-10-30 Lower Price Target DA Davidson Buy $16.00 to $13.00
2013-10-30 Lower Price Target Canaccord Genuity Buy $15.00 to $12.00
2013-10-01 Downgrade Oppenheimer Market Perform to Underperform $11.65 to $9.00
2013-10-01 Boost Price Target Canaccord Genuity Buy $12.00 to $15.00
2013-02-21 Reiterated UBS Neutral $7 to $5.50
2012-11-07 Downgrade Avian Positive to Neutral $12 to $10
2012-03-14 Upgrade Avian Neutral to Positive
2011-12-13 Upgrade Ticonderoga Sell to Neutral
2011-11-09 Downgrade UBS Buy to Neutral $12 to $11
2011-11-09 Downgrade Avian Positive to Neutral
2011-10-03 Reiterated Canaccord Genuity Hold $11 to $9
2011-08-05 Reiterated UBS Buy $28 to $15
2011-05-06 Reiterated UBS Buy $38 to $40
2011-04-26 Reiterated UBS Buy $30 to $38
2011-02-17 Reiterated UBS Buy $25.50 to $30
2011-02-17 Reiterated Kaufman Bros Buy $30 to $32
2011-01-31 Downgrade Canaccord Genuity Buy to Hold $36 to $20
2010-12-17 Downgrade Oppenheimer Outperform to Perform
2010-12-01 Initiated Kaufman Bros Buy $30
2010-11-05 Reiterated UBS Buy $41 to $36
2010-10-01 Initiated Merriman Sell
2010-06-07 Reiterated Oppenheimer Outperform $30 to $34
2010-05-10 Upgrade Oppenheimer Perform to Outperform $30
2016-05-11 Reiterated Rating Canaccord Genuity Hold $0.75
2016-02-25 Reiterated Rating Canaccord Genuity Hold $1.05 to $0.90
2015-11-10 Reiterated Rating Oppenheimer Hold
2015-11-10 Reiterated Rating Canaccord Genuity Hold $1.65 to $1.05
2015-11-10 Reiterated Rating Oppenheimer Holdings Inc. Hold

There is presents forecasts of rating agencies and recommendations for investors about this ticker

Major Shareholders

Name Relationship Total Shares Holding stocks
CROSS ATLANTIC CAPITAL PARTNERS II INC 8.48%  (2217851) RBCN /
Gazelle TechVentures, Inc. 5.98%  (1564997) RBCN /
Spencer Raymond J 0.56%  (147551) RBCN /
Brog Timothy E 0.16%  (42759) PRLS / RBCN /
Tamim Hany Chief Operating Officer 0.14%  (36333) RBCN /
MIKOLAJCZYK MICHAEL E 0.14%  (36275) RBCN /
Parvez Raja M President, CEO & Director 0.11%  (27985) RBCN /
Aquilano Don N 0.10%  (26287) RBCN /
Cross Atlantic Capital Partners, Inc. 0.08%  (19763) AMBR / RBCN /
Weissman William F CFO, Treasurer and Secretary 0.05%  (14136) RBCN /
HUNTER GORDON 0.03%  (8900) CTS / LFUS / RBCN / VECO /
Graffy Mardel A VP - Financial Operations 0.02%  (4938) RBCN /
Westphal Susan 0.02%  (4038) RBCN /